Establishing a cytology laboratory in a low-resource setting for cervical cancer screening

Edizioni Minerva Medica - Tập 8 Số 4 - Trang 239-244 - 2012
Celestino Rodrigues Pereira1, Jan‐Olaf Gebbers2
1Institute of Pathology, Cantonal Hospital Aarau, Aarau, Switzerland
2Institute of Environmental Medicine, Cantonal Hospital Lucerne, CH-6000, Luzern 16, Switzerland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Enserink M (2011) A push to fight cancer in the developing world. Science 331:1548–1550

Beaglehole, R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438–1447

Stewart BW, Kleihues P (eds) (2003) World cancer report. International Agency for Research on Cancer, World Health Organization. IARC Press, Lyon

WHO/ICO Information Centre. Human papillomavirus and related cancers: summary report update, September 2010. India. http://apps.who.int/hpvcentre/statistics/dynamic/ico/country_pdf/IND.pdf?CFID=4347898&CFTOKEN=70473061 . Accessed 3 October 2012

Coebergh JW (2011) What global protection against women’s cancers? Lancet 378:1442–1443

Lopez AD, Mathers CD, Ezzati M et al (eds) (2006) Global burden of disease and risk factors. World Bank, Washington, DC, and Oxford University Press, New York

Forouzanfar MH, Foreman K, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484

Vogel G (2012) How do you count the dead? Science 1372–1374

Law MR, Morris JK, Wald NJ (1999) The importance of age in screening for cancer. J Med Screen 6:16–20

Howitt P, Darzi A, Yang Guang-Zhong et al (2012) Technologies for global health. Lancet 380:507–535

Sankaranarayanan R, Nene BM, Shastri SS et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360:1385–1394

Zur Hausen H (2009) Papillomaviruses in the causation of human cancers — a brief historical account. Virology 384:260–265

Michels KB, zur Hausen H (2009) HPV vaccine for all. Lancet 374:268–270

Editorial (2011) Financing HPV vaccines in developing countries. Lancet 377:1544

Gerhardus A, Razum O (2010) A long story made too short: surrogate variables and the communication of HPV vaccine trial results. J Epidemiol Community Health 64:377–378

Goldie SJ, O’shea M, Campos NG et al (2008) Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 2008;26:4080–4093

Kaiser J (2012) Cancer genetics with an edge. Science 337:282–284